Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,533 Cr
P/E Ratio
49.21
P/B Ratio
4.91
Industry P/E
51.44
Debt to Equity
0.82
ROE
7.41 %
ROCE
9.59 %
Div. Yield
0.33 %
Book Value
367.07
EPS
36.61
CFO
₹333.40 Cr
EBITDA
₹502.49 Cr
Net Profit
₹273.50 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Hester Biosciences
| -24.63 | 30.19 | -16.80 | 10.93 | -11.43 | 12.41 | 10.95 |
|
BSE Healthcare
| -5.48 | 1.35 | 0.22 | 22.74 | 20.05 | 23.06 | 9.77 |
|
BSE Small Cap
| -10.07 | 4.18 | -3.21 | 7.10 | 18.99 | 35.87 | 15.84 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Hester Biosciences
| 64.46 | -18.63 | -29.24 | 49.96 | 17.66 | 24.54 | -38.82 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2,202.50 | 9,011.72 | 74.24 | 12.96 | |
| 1,147.00 | 701.24 | 21.49 | 12.02 | |
| 5,240.00 | 8,712.93 | 36.83 | 43.77 | |
| 148.72 | 3,711.98 | 318.65 | 1.73 |
Companies with less institutional holdings
4 min read•By Jugal Harpalani
1 min read•By Research Desk
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides... poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucellosis, contagious bovine pleuropneumonia, and lumpy skin diseases. In addition, the company provides animal health products, such as biosecurity and therapeutic solutions, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticide solutions, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic kits. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India. Read more
Incorporated
1987
Chairman
Bhupendra V Gandhi
Managing Director
Rajiv Gandhi
Headquarters
Mehsana, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Hester Biosciences Ltd stood at ₹ 669 Cr as on 31-Dec-24
The share price of Hester Biosciences Ltd is ₹1,808.40 (NSE) and ₹1,801.80 (BSE) as of 23-Apr-2025 IST. Hester Biosciences Ltd has given a return of -11.43% in the last 3 years.
Hester Biosciences Ltd has a market capitalisation of ₹ 1,533 Cr as on 23-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Hester Biosciences Ltd is 4.91 times as on 23-Apr-2025, a 35% discount to its peers’ median range of 7.53 times.
The P/E ratio of Hester Biosciences Ltd is 49.21 times as on 23-Apr-2025, a 4% discount to its peers’ median range of 51.44 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Hester Biosciences Ltd and enter the required number of quantities and click on buy to purchase the shares of Hester Biosciences Ltd.
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucellosis, contagious bovine pleuropneumonia, and lumpy skin diseases. In addition, the company provides animal health products, such as biosecurity and therapeutic solutions, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticide solutions, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic kits. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.
The prominent promoters of Hester Biosciences Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Rajiv Dinesh Gandhi |
10.47%
|
|
Sanjiv Dinesh Gandhi |
8.2%
|
|
Nina Rajiv Gandhi |
8.19%
|
|
Shaila Bhupendra Gandhi |
5.78%
|
|
Ravin Gandhi |
4.74%
|
The chairman of the company is Bhupendra V Gandhi, and the managing director is Rajiv Gandhi.
There is no promoter pledging in Hester Biosciences Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
3,682
|
|
|
652
|
|
|
9,512
|
|
|
8,680
|
| Hester Biosciences Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
10.49
|
|
Operating margin(%)
|
13.43
|
|
Net Margin(%)
|
9.4
|
|
Dividend yield(%)
|
0.33
|
Yes, TTM profit after tax of Hester Biosciences Ltd was ₹31 Cr.
₹6.80
(
